Practicing Self-Control Lowers the Risk of Smoking Lapse
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00349687 |
Recruitment Status
:
Completed
First Posted
: July 10, 2006
Last Update Posted
: November 23, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Behavior, Addictive Cigarette Smoking | Behavioral: self-control practice | Phase 1 Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 120 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | Practicing Self-Control Lowers the Risk of Smoking Lapse |
Study Start Date : | May 2004 |
Actual Primary Completion Date : | March 2009 |
Actual Study Completion Date : | March 2009 |

- smoking cesssation [ Time Frame: 1 month ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- smoked at least 10 cigarettes per day for at least two years
- currently smoking
Exclusion Criteria:
- have at least an 8th grade education level
- have a working touch-tone phone
- report low motivation and efficacy to quit

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00349687
United States, New York | |
University at Albany | |
Albany, New York, United States, 12222 |
Principal Investigator: | Mark Muraven, Ph.D. | University at Albany |
Responsible Party: | Mark Muraven, Associate Professor, University at Albany |
ClinicalTrials.gov Identifier: | NCT00349687 History of Changes |
Other Study ID Numbers: |
DA016131 R01DA016131 ( U.S. NIH Grant/Contract ) |
First Posted: | July 10, 2006 Key Record Dates |
Last Update Posted: | November 23, 2011 |
Last Verified: | November 2011 |
Additional relevant MeSH terms:
Behavior, Addictive Compulsive Behavior Impulsive Behavior |